, multivariable models assessed associations between KPS and outcomes. LT recipients needing full assistance (KPS 10%-40%) vs being independent (KPS 80%-100%) were more likely to be discharged to a rehabilitation facility after LT (22% vs 3%) and be rehospitalized within the first posttransplant year (78% vs 57%), all P < .001. In adjusted generalized linear models, in addition to MELD (P < .001), factors independently associated with higher 1-year post-LT transplant costs were older age, poor functional status (KPS 10%-40%), living donor LT, pre-LT hemodialysis, and the donor risk index (all P < .001). One-year survival for patients in the top cost decile was 83% vs 93% for the rest of the cohort (log rank P < .001). Functional status is an important determinant of posttransplant resource utilization; therefore, standardized measurements of functional status should be considered to optimize candidate selection and outcomes. 
organ transplant recipients with greater frailty have more postoperative complications, 13 early hospital readmissions, 14 and graft loss, independent of age. 15 A recent study in patients with cirrhosis showed that the addition of functional status as measured by Karnofsky
Performance Status (KPS) improved the prediction for 3-month mortality after a cirrhosis-related hospitalization. 16 In the general population, poor functional status or frailty has also been associated with greater ambulatory expenditures, 17 emergency room visits, and hospitalizations. 18, 19 However, the independent contribution of functional impairment irrespective of liver disease severity (eg MELD score) to LT-related costs has not been well elucidated.
The evaluation of factors guiding transplant-care expenditures is particularly salient in light of ever-increasing healthcare costs, as well as continued efforts to develop and restructure cost-sharing policies to reduce unsustainable budgetary deficits. 20 Alternatives to fee-forservice reimbursements have focused on value-based care; in fact, the US Department of Health and Human Services had set a goal to link 90% of Medicare hospital payments to quality by the end of 2018,
with trends under way in the private sector. 21 In the case of abdominal organ transplantation, payment bundling, which would treat the transplant admission and immediate posttransplant period as a single care
episode, has not yet been implemented by Medicare, but may be on the horizon. These changing payment models may affect the willingness of transplant centers to provide LT to the sickest, most debilitated patients who are currently favored by the MELD allocation system 22, 23 and may critically alter clinical practice if the costs of transplantation are too high relative to reimbursement. As value-based payments continue to be an emerging trend, predicting transplant costs a priori may be of value when negotiating with payers. The objective of this study was to provide an in-depth examination of the associations between functional status at transplantation, healthcare utilization, and transplant-related costs among a diverse sample of patients undergoing LT at a large US transplant center. Secondary analyses evaluated associations between high costs and 1-year patient survival.
| MATERIALS AND METHODS
This was a single-center retrospective cohort study from the University Data regarding demographics, insurance coverage, healthcare utilization (eg transplant LOS, ventilator days, hemodialysis days, admission source, and discharge status) and costs were derived from the center's general ledger and cost accounting system.
| Study sample and eligibility criteria
The initial study cohort included all patients who underwent LT during the study period. Patients were excluded if they had fulminant liver failure, underwent multi-organ transplantation with liver-heart or liver-lung, or required re-transplantation within 1 year. Simultaneous liver-kidney (SLK) transplant recipients were included because the primary indication for LT in these patients was liver disease. In addition, 1 extreme cost outlier (>99.5 th percentile, cost at 13 times the median)
was excluded from the analysis because the recipient was not representative of the overall cohort. To assess the external validity of the results, demographic and clinical characteristics of the study cohort were compared to a national cohort of patients transplanted during the study period who fulfilled similar study eligibility criteria.
| Study outcomes
The primary outcomes evaluated were the overall total and direct per-patient costs at the end of the first posttransplant year, which included the cost of the LT hospitalization and subsequent inpatient and outpatient encounters. Total costs, in US dollars, were defined as the transplant center input costs and derived from the center's cost accounting system, which aggregated patient-level costs on the basis of the following: (1) services utilized (eg physician consultation, procedure, nursing), (2) location of services performed (eg hospital unit, emergency department, outpatient clinic), and (3) additional overhead costs (ie indirect costs). Organ acquisition costs and living donor costs were included within the per-patient costs. The rationale for reporting both total and direct costs as primary outcomes was as follows:
health-system total costs were more stable than direct costs during the study period as the definitions of direct and indirect costs changed over time (direct cost data from 1 fiscal year could include costs that were classified as indirect in a subsequent year). Although there was more variability in direct costs, they were also reported to maximize transparency. To account for inflation, costs were adjusted to match the 2014 equivalents using the Consumer Price Index for Medical Services provided by the US Bureau of Labor Statistics. 24 The proportions of total costs attributed to inpatient and outpatient episodes of care, including hospital and physician-associated costs were also computed. Secondary outcomes included additional total and direct healthcare costs accrued during the following periods: (1) 180 days prior to LT, and (2) the LT hospitalization and 1 year posttransplant survival.
| Ascertainment of functional status
Functional status was measured using the KPS score, a clinician-rated measure initially developed for oncology patients, which has been validated across multiple healthcare settings. 25 The score estimates the ability to perform activities of daily living and is measured from 0 to 100% according to the following criteria: no assistance needed as KPS 80%-100%, minimal assistance as KPS 50%-70%, and full assistance as KPS 10%-40%, 26 with death categorized as KPS 0%. Thus, if patients needed any assistance at all for activities of daily living, their KPS score could be no more than 70%. The KPS at evaluation and at transplantation was obtained via medical record review by a trained transplant professional and confirmed individually with each LT recipient's primary treating physician. In cases of disagreement between the 2 raters, the final score was determined using the pre-LT physician's assessment. Multivariable generalized linear models with a gamma distribution and a log-link function were used to evaluate total and direct costs in the first year post-LT, the primary outcomes of interest. These are standard methods to evaluate costs, which have skewed distributions.
| Statistical analysis
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The modified Park test was used to confirm the appropriateness of the gamma distribution. Models were constructed using purposeful selection procedures whereby the primary exposure of interest (functional status measured by KPS at transplantation), demographic, and clinical variables with P < .10 in univariable analyses were initially explored.
Covariates initially evaluated included age, sex, race, body mass index, etiology of liver disease, MELD score at LT, receipt of SLK, hemodialysis at least twice in the week prior to LT, ventilator support prior to LT, receipt of HCC MELD exception, living donor LT, total days on the waitlist, and DRI. 28 Final models included covariates with P < .05 or those that confounded the relationship between functional status and costs by changing the effect estimates by at least 10%. Functional status by KPS was initially evaluated as a 3-level categorical exposure:
KPS (10%-40%, 50%-70%, and 80%-100%) as done in other studies. 29, 30 However, in univariable analyses, only the category with the most pronounced functional impairment (10%-40%) was associated with increased costs. Therefore, KPS was ultimately evaluated as a dichotomous variable: needing full assistance (10%-40%) vs mostly/ completely independent (50%-100%). Interactions between recipient age, functional status, and MELD at LT were assessed. Postestimation analyses were performed to compute total and direct costs according to calculated MELD score and functional status at LT. As a secondary analysis, 1 year post-LT survival was estimated using the Kaplan-Meier method comparing patients in the highest cost decile 365 days after LT to the remainder of the cohort.
To explore the generalizability of the noted associations between functional status and posttransplant healthcare utilization in our single-center study, we performed a subanalysis of UNOS data during the same period among 29 883 LT recipients. We evaluated the outcome of transplant LOS as a surrogate for cost. We examined national posttransplant LOS with a generalized linear mixed model using log transformation to stabilize variance and ensure normality of the residuals. Random center effects were used to allow for variation between transplant centers. We included the same covariates as in our singlecenter experience (age, MELD, KPS, living donor, hemodialysis, and DRI). All analyses were conducted using Stata version 13.0 (StataCorp, College Station, TX). This study was approved after expedited review by the University of Pennsylvania Institutional Review Board.
| RESULTS
A total of 638 adult patients underwent LT during the study period.
After excluding 6 patients with fulminant liver failure, 21 with liverheart or liver-lung, 12 with retransplantation within 12 months, and 1 severe cost outlier, the final analytic cohort included 598 patients.
Baseline demographic and clinical characteristics stratified by KPS are shown in Table 1 . A total of 41.5% of the cohort had a KPS score of 10%-40% at LT, thereby requiring full assistance in their activities of daily living, whereas 20.1% were fully independent with KPS score 80%-100%. Compared to those with KPS 80%-100%, patients with KPS score 10%-40% were less likely to be male (65.7% vs 79.2%; P = .021 comparing all 3 KPS groups), less likely to have HCC, and more likely to have alcoholic liver disease (P < .001). Median days on the waitlist was markedly shorter in this group (83 days vs 295 days for KPS 80%-100%; P < .001 comparing all 3 KPS groups), while median calculated MELD at LT was higher (31 vs 12 for KPS 80%-100%; P < .001 comparing all 3 KPS groups). Compared to UNOS national transplant data for the same period (Table S1 ), patients from the study cohort were older, more likely to be male, black, and have hepatitis C virus as the primary liver disease diagnosis; whereas they were less likely to receive SLK (all P < .05). Notably, there were no significant differences in the distribution of KPS scores between the singlecenter study cohort and national data, with about 20% of LT recipients in the independent category (KPS 80%-100%) and about 40% requiring significant assistance (KPS 10%-40%) at LT (P = .393).
Healthcare utilization and posttransplant outcomes stratified by KPS score at LT are shown in Table 2 . Compared to LT recipients with KPS of 80%-100%, those with KPS of 10%-40% were more likely to be hospitalized at LT (62.9% vs 2.5% for KPS 80%-100%; P < .001 Table 3 . A stepwise absolute increase in costs was noted with each decrement in functional status for both total and direct costs at each transplant time period (all P < .05). For the main outcome (costs in the first post-LT year), patients with KPS 10%-40% had $79 261 (45%) higher total costs and $52 411 (42%)
higher direct costs compared to those with KPS 80%-100%. The most dramatic increase in costs was noted in the 180 days prior to LT, where direct costs nearly tripled ($4,602 vs $13,515) between LT recipients who were functionally independent (KPS 80%-100%) and those needing maximal assistance (KPS 10%-40%). Figure 1 shows the proportion of total costs attributed to inpatient vs outpatient and physician vs hospital care for the cohort. Overall, most LT-related costs (70%)
were incurred during the LT inpatient admission and were attributed to costs of inpatient care.
Results of the multivariable analyses for the outcomes of total and direct costs in the first post-LT year are shown in Table 4 .
Factors independently associated with higher total and direct costs included age, MELD score at LT, KPS 10%-40% (needing full assistance) vs 50%-100%, receipt of living donor liver transplant, dialysis at least twice in 1 week prior to LT, and DRI. Postestimation adjusted total costs in the first posttransplant year plotted against MELD and stratified by KPS scores are shown in Figure 2 . Recipients with KPS score 80%-100% had relatively stable costs at increasing MELD scores. However, patients with KPS scores of 50%-70% and 10%-40% were noted to have increasing costs with incremental increases in MELD; the slope of the increase appeared greatest for MELD scores around 28.
Additional postestimation analyses evaluated adjusted total costs within the first year post-LT according to KPS score and MELD ≥25 vs <25 (Figure 3 ). Costs were notably higher across all KPS categories for those with MELD ≥25 compared to <25. Figure 4 shows the results of secondary analyses evaluating the association between the highest cost decile and 1-year survival. Unadjusted 1-year survival was 83% in the group of patients who were in the highest cost decile (n = 59) compared to 93% in the rest of the cohort (log rank P < .001).
Results of the additional analyses evaluating associations between MELD, KPS, and transplant LOS using national UNOS data are reported in Table S2 . Similar to the main analyses, MELD and T A B L E 2 Healthcare utilization and posttransplant outcomes stratified by functional status at LT (N = 598) KPS 10%-40% compared to KPS of 50%-100% were associated with increased transplant LOS (all P < .001). Additionally, all the same covariates were associated with increasing transplant LOS in the UNOS data as in the single-center data (living donor liver transplant, dialysis at least twice in 1 week prior to LT, and DRI; all P < .001).
Finally, using an interaction, we found that the Penn center effect did not change the direction of the individual parameter estimates on posttransplant LOS.
| DISCUSSION
Since the beginning of the MELD era, the medical complexity and liver disease severity of waitlisted LT candidates has increased dramatically. The concomitant increase in value-based reimbursement models may result in increasing transplant center financial burden and could lead to future risk aversion, particularly in high MELD regions.
This study is one of the first to comprehensively examine the contribution of functional status in addition to medical comorbidity and liver disease severity to per-patient costs incurred by the transplant center. While the results presented here were obtained from a single center in the United States, we showed using national data that poor functional status contributed to posttransplant LOS as much as an absolute increase of 13.5 MELD points.
In this study, we showed additional and independent contributors to posttransplant-associated costs such as age, clinician-rated patient functional status, hemodialysis, and donor factors captured by the DRI. Furthermore, transplant costs were largely accounted for by inpatient utilization and were disproportionately increased among recipients with high MELD and poor performance status. Direct costs in the 180 days prior to LT more than tripled with worsening functional status, and those accrued in the first year after LT increased by >40%.
Moreover, adjusted total costs within the first year after LT significantly increased with increasing MELD score for recipients with KPS scores of 50%-70% and 10%-40%. This increase occurred even at low MELD scores, though it was particularly sharp once patients reached a MELD score of 28.
The findings of this study should be placed within the growing body of evidence that frailty and functional decline are associated with increased posttransplant mortality, 29 longer LT LOS, and postoperative complications. 13, [31] [32] [33] By stratifying according to KPS score, this study was able to more effectively evaluate the relationship between functional status and costs. While it is intuitive that poor functional status predicts poor outcomes post-LT, this study demonstrates that functional status is an independent predictor of resource utilization post-LT irrespective of MELD score and other measures of illness severity. Moreover, this research is unique in that it explored these relationships with respect to actual hospital operating costs and overcomes some of the limitations of previous studies that reported adjusted charges, which could have been distorted by payer reimbursement. concern even after transplantation, and impacts not only the costs of care but also patient and graft survival. 35 In fact, it has been suggested that functional status may be a stronger predictor of readmission risk than standard comorbidity scores. 36 While the number of hospital admissions and the costs of hospitalization per year for patients with cirrhosis have doubled in the last 15 years, 37 the drive by hospitals to reduce readmission rates in the face of lower reimbursement have been highly relevant. In efforts to improve patient outcomes and cut costs, initiatives aimed at identifying those with the highest readmission rates 38 and highest likelihood of posttransplant rehabilitation needs have been employed by several centers. 39 However, relatively few of these interventions in the LT setting have formally incorporated functional status and frailty assessments, despite these measures being well validated in other populations.
Based on the available literature, poor performance status appears to be predictable and portends worse long-term posttransplant outcomes; however, interventions in transplantation have been few. In other settings such as geriatrics, interventions that improve physical mobility and decrease frailty have been shown to be cost-effective and even cost-saving. 40, 41 In the surgical literature, it has been shown that prehabilitation programs, which aim to optimize physical and nutritional status, improve outcomes after major abdominal surgery 42, 43 and that reversal of sarcopenia may reduce postoperative LOS and healthcare costs. 44 However, few studies have evaluated the impact of prehabilitation programs on postoperative outcomes in LT. Early reports suggest feasibility of prehabilitation in LT candidates, 45, 46 but it remains to be seen whether they improve waitlist and posttransplant outcomes and are cost-effective.
This study had several limitations. This was a single-center cohort study potentially limiting generalizability; however, KPS scores were similar when compared to national UNOS data for the same time period. Furthermore, when we tested our covariates using UNOS data on transplant LOS, we found that our model was robust and all co- were not obtained and longitudinal measurements were not performed.
Finally, total costs may have been underestimated, as we were not able to capture costs of rehabilitation at nontransplant center facilities, the costs of admission at other hospitals, and outpatient pharmacy costs.
In conclusion, poor functional status at LT was significantly as- 
